C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2011
10/19/2011	EP2377890A2 Antibodies
10/19/2011	EP2377889A2 Antibodies
10/19/2011	EP2377888A1 Fusion protein
10/19/2011	EP2377887A1 Antibodies that bind both IL-17A and IL-17F and methods of using the same
10/19/2011	EP2377886A1 Antibody glycosylation in the variable region
10/19/2011	EP2377885A1 Method for producing comprehensive anti-surface antibody wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent
10/19/2011	EP2377883A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
10/19/2011	EP2377555A2 Antibodies against vascular endothelial growth factor receptor-1
10/19/2011	EP2377554A1 Concentrated protein lyophilates, methods and uses
10/19/2011	EP2377527A1 Polyelectrolyte precipitation and purification of antibodies
10/19/2011	EP2376654A2 Vaccines targeting cellular death receptors
10/19/2011	EP2376632A1 Compositions, methods and related uses for cleaving modified dna
10/19/2011	EP2376537A2 Human antibodies against human tissue factor.
10/19/2011	EP2376536A2 Remedies for pemphigus containing anti fas ligand antibodies
10/19/2011	EP2376535A1 Anti-pd-l1 antibodies and their use to enhance t-cell function
10/19/2011	EP2376534A1 Sparc binding scfcs
10/19/2011	EP2376533A1 Antibody formulation
10/19/2011	EP2376532A2 Organic compounds
10/19/2011	EP2376526A1 Modified streptococcus pneumoniae pneumolysin (ply) polypeptides
10/19/2011	EP2376523A1 Precipitation of biomolecules with negatively charged polymers
10/19/2011	EP2376126A2 Antagonists of il-6 to prevent or treat thrombosis
10/19/2011	EP2376122A2 Agent for prophylaxis or treatment of cancer
10/19/2011	EP2376121A1 Osteoarthritis treatment
10/19/2011	EP2376119A1 Anti-hcv monoclonal antibody as a medicament for the therapeutic treatment and prevention of hcv infections
10/19/2011	EP2376117A1 Hepatitis c virus combination therapy
10/19/2011	EP2376116A2 Anti-igf antibodies
10/19/2011	EP2376108A2 IgE CH3 PEPTIDE VACCINE
10/19/2011	EP2231706B1 Biokinetics of fast-clearing polypeptides
10/19/2011	EP1930346B1 Antibody produced using ostrich and method for production thereof
10/19/2011	EP1762610B1 Truncated dance, dance complex and method of using these
10/19/2011	EP1573323B1 Prion protein ligands and methods of use
10/19/2011	EP1563308B1 Methods and kits for diagnosing tumorigenicity
10/19/2011	EP1451338B1 Recombinant antibodies for the detection and neutralization of anthrax toxin
10/19/2011	CN1869235B Method for modifying plant morphology, biochemistry and physiology
10/19/2011	CN102224420A Prediction and prevention of preeclampsia
10/19/2011	CN102224255A Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response
10/19/2011	CN102224239A High titer antibody production
10/19/2011	CN102224171A Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection
10/19/2011	CN102224170A Materials and methods for inhibiting cancer cell invasion related to fgfr4
10/19/2011	CN102224169A Polypeptides, antibody variable domains & antagonists
10/19/2011	CN102224168A Composition for producing anti-amyloid beta peptide antibodies with d-peptides
10/19/2011	CN102224167A Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
10/19/2011	CN102224160A Aqueous two phase extraction augmented precipitation process for purification of therapeutic proteins
10/19/2011	CN102221615A Double-antibody sandwich ELISA method based on Angiogenin detection
10/19/2011	CN102220423A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/19/2011	CN102220288A Mouse-addapted enterovirus EV71 strain 573 and use thereof
10/19/2011	CN102220286A Hybridoma cell strain 2C9, anti-aflatoxin M1 monoclonal antibody produced by hybridoma cell strain 2C9 and application thereof
10/19/2011	CN102220285A Monoclonal antibody of outer membrane protein of chlamydia abortus and application thereof
10/19/2011	CN102219857A IgG-IgM polymer and polymerization method thereof
10/19/2011	CN102219856A Vascular Endothelial Growth Factor (VEGF) acceptor 2/CD3 bispecific single-chain antibody
10/19/2011	CN102219855A High-affinity anti-EGFR (epidermal growth factor receptor) monoclonal antibody
10/19/2011	CN102219854A Monoclonal antibody of anti-human PIGF (placental growth factor) protein as well as preparation method and application thereof
10/19/2011	CN102219853A Anti-H5N1 type bird flue virus vicuna VHH heavy chain antibody as well as preparation method and application thereof
10/19/2011	CN101550189B Anthropogenic antivirulin glycosidoprotein neutralizing genetic engineering antibody RD9 and preparation and application thereof
10/18/2011	US8039607 Probe, probe set, probe carrier, and testing method
10/18/2011	US8039603 Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
10/18/2011	US8039600 Monoclonal antibodies
10/18/2011	US8039599 Rapamycin assay
10/18/2011	US8039598 Met fab and SCFV fragments
10/18/2011	US8039597 Antibodies and related molecules that bind to 24P4C12 proteins
10/18/2011	US8039596 Alpha 5-beta 1 antibodies and their uses
10/18/2011	US8039595 Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation
10/18/2011	US8039593 Antibodies and immunotoxins that target human glycoprotein NMB
10/18/2011	US8039592 Optimized Fc variants and methods for their generation
10/18/2011	US8039585 for use in treatment and prevention of vision defects and cell proliferative disorders
10/18/2011	US8039582 Peptide networks
10/18/2011	US8039273 Antibodies; anticancer agents; autoimmune disorders
10/18/2011	US8039257 Pre-transplant accomodated organs resistant to anti-donor immunity
10/18/2011	US8039226 Anti NC1 monoclonal antibody
10/18/2011	US8039220 Stabilized standards for busulfan immunoassay
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	US8038999 Breast cancer eradication program
10/18/2011	US8038997 Anti-marinobufagenin antibodies and methods for their use
10/18/2011	US8038995 Human N-type calcium channel isoform and uses thereof
10/18/2011	US8038994 Synergistic administration of a xenotypic antibody and an anticarcinogenic agent; immunotherapy
10/18/2011	US8038986 Immunogenic compositions and diagnostic and therapeutic uses thereof
10/18/2011	US8038983 Fluorinated carbohydrate conjugates
10/18/2011	CA2561800C Anti-gluten egg yolk antibodies for the treatment of celiac disease
10/18/2011	CA2506329C Candida kefyr cytosine deaminase
10/18/2011	CA2478658C Sandwich immunoassay kits for detecting ciguatoxin ctx3c
10/18/2011	CA2446189C Peptides and related molecules that bind to tall-1
10/18/2011	CA2328515C Continuous in-vitro evolution
10/18/2011	CA2323572C Vertebrate patched-2 protein
10/18/2011	CA2252986C Process for preparing functional recombinant tissue factor
10/18/2011	CA2232237C Reagents and methods useful for detecting diseases of the breast
10/18/2011	CA2221682C Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
10/18/2011	CA2213833C Vascular endothelial cell growth factor antagonists
10/13/2011	WO2011127472A1 Compositions and methods for providing hematopoietic function
10/13/2011	WO2011127470A1 Compositions and methods for providing hematopoietic function without hla matching
10/13/2011	WO2011127412A2 Soluble human st-2 antibodies and assays
10/13/2011	WO2011127324A2 Antibodies to cd122
10/13/2011	WO2011126577A2 Method for the generation of monoclonal antibodies derived from human b cells
10/13/2011	WO2011126576A2 Genetic signatures in the envelope glycoprotein of hiv-1
10/13/2011	WO2011125875A1 Novel monoclonal antibody and method for immunoassaying d dimer
10/13/2011	WO2011125673A1 Filler for affinity chromatography
10/13/2011	WO2011125458A1 Marker for diagnosing effect of anticancer agent
10/13/2011	WO2011125139A1 Cluap1 peptides and vaccines including the same
10/13/2011	WO2011124869A1 Self-assembling half-antibodies
10/13/2011	WO2011124668A1 Plasma-derived immunoglobulin for use in the treatment and prevention of immune reconstitution inflammatory syndrome (iris)
10/13/2011	WO2011124635A1 Binding molecules against chikungunya virus and uses thereof

1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 1494